Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Summary

This is a randomized, open-label, phaseⅡ study evaluating efficacy and safety of DC (dendritic cells) vaccine concurrent with chemotherapy compared to chemotherapy alone in patients with stage IV NSCLC (non small cell lung cancer) with wild-type EGFR (epidermal growth factor receptor).

Timeline

Start

2016-01

Primary completion

2017-01

Completion

2019-01

Drugs

Indications